Literature DB >> 20727038

B-cell stage and context-dependent requirements for survival signals from BAFF and the B-cell receptor.

Fabienne Mackay1, William A Figgett, Damien Saulep, Melanie Lepage, Margaret L Hibbs.   

Abstract

One remarkable feature of the immune system is its capacity to maintain constant numbers of resting immune cells despite the complex nature of signals needed throughout development and maturation. For many years, B-cell survival was thought to rely solely on B-cell receptor (BCR) tonic signals that would trigger necessary basal survival pathways. The discovery of the tumor necrosis factor (TNF)-like ligand BAFF(B-cell activating factor belonging to the TNF family)/BLyS (B-lymphocyte stimulator) changed these views entirely, as BAFF-deficient mice lack most mature B cells, and treatment with BAFF inhibitors leads to their loss, establishing BAFF as an unappreciated key B-cell survival factor. BAFF-mediated survival signals have been mapped and signaling crosstalk with the BCR has been identified, explaining the need for both BCR- and BAFF-mediated signals for B-cell survival. However, this crosstalk only explains how BCR and BAFF signals cooperate to produce survival proteins and yet, inactivating pro-apoptotic factors such as FOXO proteins, which may be managed separately by BAFF and the BCR, has emerged as an equally important step for survival. In this review, we present new views on B-cell survival, at all stages of B-cell life, and suggest that, in most cases, survival results from the production of appropriate survival factors balanced with the adequate and timely degradation of pro-apoptotic proteins.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20727038     DOI: 10.1111/j.1600-065X.2010.00944.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  80 in total

1.  The cytokine midkine and its receptor RPTPζ regulate B cell survival in a pathway induced by CD74.

Authors:  Sivan Cohen; Or-yam Shoshana; Einat Zelman-Toister; Nitsan Maharshak; Inbal Binsky-Ehrenreich; Maya Gordin; Inbal Hazan-Halevy; Yair Herishanu; Lev Shvidel; Michal Haran; Lin Leng; Richard Bucala; Sheila Harroch; Idit Shachar
Journal:  J Immunol       Date:  2011-12-02       Impact factor: 5.422

2.  Soluble multi-trimeric TNF superfamily ligand adjuvants enhance immune responses to a HIV-1 Gag DNA vaccine.

Authors:  Saravana K Kanagavelu; Victoria Snarsky; James M Termini; Sachin Gupta; Suzanne Barzee; Jacqueline A Wright; Wasif N Khan; Richard S Kornbluth; Geoffrey W Stone
Journal:  Vaccine       Date:  2011-12-04       Impact factor: 3.641

3.  Genetic variation in B cell-activating factor of the TNF family (BAFF) and asthma exacerbations among African American subjects.

Authors:  Rajesh Kumar; L Keoki Williams; Atsushi Kato; Edward L Peterson; Silvio Favoreto; Katie Hulse; Deli Wang; Kenneth Beckman; Shannon Thyne; Michael LeNoir; Kelley Meade; David E Lanfear; Albert M Levin; David Favro; James J Yang; Kevin Weiss; Homer A Boushey; Leslie Grammer; Pedro C Avila; Esteban G Burchard; Robert Schleimer
Journal:  J Allergy Clin Immunol       Date:  2012-06-22       Impact factor: 10.793

Review 4.  B-1 B cell development in the fetus and adult.

Authors:  Encarnacion Montecino-Rodriguez; Kenneth Dorshkind
Journal:  Immunity       Date:  2012-01-27       Impact factor: 31.745

Review 5.  The rationale for BAFF inhibition in systemic lupus erythematosus.

Authors:  Anne Davidson
Journal:  Curr Rheumatol Rep       Date:  2012-08       Impact factor: 4.592

Review 6.  BAFF and selection of autoreactive B cells.

Authors:  Zheng Liu; Anne Davidson
Journal:  Trends Immunol       Date:  2011-07-13       Impact factor: 16.687

7.  Innate immune defects correlate with failure of antibody responses to H1N1/09 vaccine in HIV-infected patients.

Authors:  Suresh Pallikkuth; Sudheesh Pilakka Kanthikeel; Sandra Y Silva; Margaret Fischl; Rajendra Pahwa; Savita Pahwa
Journal:  J Allergy Clin Immunol       Date:  2011-07-12       Impact factor: 10.793

Review 8.  Targeting BAFF in autoimmunity.

Authors:  Anne Davidson
Journal:  Curr Opin Immunol       Date:  2010-10-21       Impact factor: 7.486

9.  The endoplasmic reticulum-resident E3 ubiquitin ligase Hrd1 controls a critical checkpoint in B cell development in mice.

Authors:  Yi Yang; Sinyi Kong; Yana Zhang; Johanna Melo-Cardenas; Beixue Gao; Yusi Zhang; Donna D Zhang; Bin Zhang; Jianxun Song; Edward Thorp; Kezhong Zhang; Jinping Zhang; Deyu Fang
Journal:  J Biol Chem       Date:  2018-06-15       Impact factor: 5.157

10.  T Cells Regulate Peripheral Naive Mature B Cell Survival by Cell-Cell Contact Mediated through SLAMF6 and SAP.

Authors:  Lihi Radomir; Sivan Cohen; Matthias P Kramer; Eszter Bakos; Hadas Lewinsky; Avital Barak; Ziv Porat; Richard Bucala; Polina Stepensky; Shirly Becker-Herman; Idit Shachar
Journal:  J Immunol       Date:  2017-09-13       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.